Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.7M
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
27.2M
-
Shares change
-
+3.46M
-
Total reported value, excl. options
-
$268M
-
Value change
-
+$16.7M
-
Put/Call ratio
-
1.37
-
Number of buys
-
68
-
Number of sells
-
-48
-
Price
-
$9.85
Significant Holders of Altimmune, Inc. - Common Stock (ALT) as of Q2 2021
148 filings reported holding ALT - Altimmune, Inc. - Common Stock as of Q2 2021.
Altimmune, Inc. - Common Stock (ALT) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.2M shares
of 80.7M outstanding shares and own 33.69% of the company stock.
Largest 10 shareholders include STATE STREET CORP (3.68M shares), VR Adviser, LLC (3.5M shares), BlackRock Inc. (2.56M shares), VANGUARD GROUP INC (1.59M shares), Point72 Asset Management, L.P. (1.56M shares), CREDIT SUISSE AG/ (1.43M shares), CITADEL ADVISORS LLC (1.29M shares), BAKER BROS. ADVISORS LP (1.07M shares), MARSHALL WACE, LLP (929K shares), and D. E. Shaw & Co., Inc. (828K shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.